Incyte Corporation – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: INCY
Share price (8/21/26): $127.81
Market cap (8/21/26): $25.9 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2

from SC 13D/A 1 page Joint Filing Agreement

12/34/56

EX-2.2

from 8-K 5 pages Amendment to Agreement and Plan of Merger

12/34/56

EX-2.1

from 8-K 77 pages Agreement and Plan of Merger Among Incyte Genomics, Inc., Maxia Pharmaceuticals, Inc. and Other Parties Signatory Hereto November 11, 2002

12/34/56

EX-2.1

from SC 13G/A 1 page Statement of Control Person

12/34/56

EX-2.1

from SC 13G 1 page Statement of Control Person

12/34/56

EX-2.1

from SC 13G 1 page Statement of Control Person

12/34/56

EX-2.1

from SC 13G 1 page Statement of Control Person

12/34/56

EX-2

from SC 13G/A 1 page Id and Classification of Subsidiary

12/34/56

EX-2.1

from 8-K ~50 pages Plan of reorganization, merger, acquisition or similar

12/34/56

EX-2

from SC 13G/A 1 page Plan of reorganization, merger, acquisition or similar

12/34/56

EX-2

from SC 13G/A 1 page Plan of reorganization, merger, acquisition or similar

12/34/56

EX-2.1

from 8-K >50 pages Share Purchase Agreement

12/34/56

EX-2.1

from 8-K ~50 pages Exhibit 2.1 to Form 8-K

12/34/56

EX-2.1

from 8-K ~50 pages Exhibit 2.1 to Form 8-K

12/34/56

Incyte Corporation – Plans of Reorganization, Merger, Acquisition or Similar Watch

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

Incyte Corporation – Plans of Reorganization, Merger, Acquisition or Similar